Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis

NCT02808780 is registered in ClinicalTrials.gov with Janssen Biotech, Inc. as lead sponsor.

NCT NCT02808780
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02808780 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis
Lead sponsor
Janssen Biotech, Inc.
Phase
Observational
Overall status
Active, not recruiting
Start date
December 16, 2016
Completion date
March 11, 2027
Enrollment
535 (actual)
Sites
63

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis